The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has partnered with Stayhealthy, Inc. to distribute Stayhealthy’s Multi-Risk Test across North America, marking a ...

Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health and wellness space across global markets along with its expanding product portfolio ...

Genetic Technologies (NASDAQ:GENE) stock tumbled 26% in afternoon trading Thursday after the genomics-based test developer announced a $2M registered direct offering. Shares of Genetic Technologies ...

Thank you for joining us, and afternoon for those joining us from the U.S. I’m really pleased to have both Simon Morriss, the Chief Executive Officer of Genetic Technologies; and Tony Di Pietro, the ...

Nearly 80% of people in Australia and the U.S. that used Genetic Technologies Ltd.’s Genetype multi-risk assessment test showed an elevated risk for at least one disease covered by the test.

The AI-based technology GEM diagnosis genetic disease in critically-ill children with high accuracy. Photo credit: Charlie Ehlert An artificial intelligence (AI)-based technology rapidly diagnoses ...

Genetic Technologies ( ($AU:GTG) ) has issued an update. Genetic Technologies Limited announced the resignation of Mr. Mark Ziirsen as the Joint ...